ECB policy meeting; US curve flattening (again)


ECB starts year-long strategic review. US curve could swing back to steepening.
Radhika Rao, Duncan Tan24 Jan 2020
    Photo credit: AFP Photo


    Eurozone: Back to externals after uneventful ECB review

    The only key takeaway from yesterday was the ECB signalling the official start of the year-long strategic review. The economic assessment, of stabilisation in growth and moderate increase in inflation, was seen along the central bank’s baseline expectations, warranting no change in the policy stance. There is a broad understanding now that monetary policy has hit its limits in lifting growth and boosting inflation, without further adversely impacting the financial system. Status quo is likely on the rates front, while any withdrawal from QE purchases is pushed back to next year.

    The strategic review, likely to be concluded by December, will involve a relook and assessment of ECB’s price stability mandate and its policy toolkit, amongst other things. Acknowledging the uphill task to arrive at a consensus, ECB’s Lagarde hinted that if there was no unanimity, it will be a majority decision. Compared to the prevailing “below but close to 2%” inflation target expectations are that it might be tightened to either a straight “2%” target (raising the bar for policy normalisation) or introduce some flexibility to achieving its price stability goal via a symmetric inflation target. Either way, there is bound to be fierce debates around these changes, which will consume much of the ECB’s time this year, with no change in rates/ policy stance in the interim.

    As noted in the Eurozone’s section of our G3 rates outlook (PDF, HTML), given the lack of immediate catalysts that could drive further curve steepening or much higher rates, we are reluctant to chase at current levels. With rate hike expectations not on the horizon and only modest fiscal easing upcoming, the supply / dynamics (with the ECB maintaining asset purchases) still point to generally depressed EUR rates.

    Rates: US yield curve flattening again

    A measure of speculative positioning on US curve slope, based on position differentials (futures) between short (Eurodollar, 2Y and 5Y T-Notes) and long (10Y T-Note, T-Bond and Ultra T-Bond) tenors, showed a swing of expectations from flattening to steepening until this week, when pandemic fears ensued. At present, USD IRS are pricing for 2s10s spread to widen from 11bps (spot) to 24bps (1Y forward). 13bps of steepening may seem underwhelming, but it is actually quite significant from a historical perspective. Looking back to 2000, the US curve has priced for steepening (on 1Y forward basis) on only 28% of the time, and when it did, it never priced for more than 30bps of steepening (vs max 145bps priced for flattening).



    Assuming pandemic fears dissipate soon, the combination of Fed buying Bills and US Treasury restarting 20Y Bond issuance could provide impulse for steepening. Over the longer-term, inflation could be a potential game changer with the Fed seeming intent on engineering higher inflation. Chair Powell has been reiterating that he would need to see “a significant move up in inflation that’s also persistent” before considering hiking rates again. The Fed’s ongoing review of its framework could also see the introduction of inflation-averaging rules that would allow for some overshooting. Therefore, a Fed that would be somewhat slow to hike rates in response to rising inflation could drive a steeper curve. Tactically though, Wuhan virus worries and heavy speculative steepening positions suggests that it would be better to await better levels before establishing steepening trades.


    Radhika Rao

    Economist – India, Thailand & Eurozone
    radhikarao@dbs.com

    Duncan Tan

    FX and Rates Strategist - Asean
    duncantan@dbs.com


    The information herein is published by DBS Bank Ltd and PT Bank DBS Indonesia (collectively, the “DBS Group”). It is based on information obtained from sources believed to be reliable, but the Group does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation & the particular needs of any specific addressee. The information herein is published for the information of addressees only & is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Group, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Group or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Group & its associates, their directors, officers and/or employees may have positions or other interests in, & may effect transactions in securities mentioned herein & may also perform or seek to perform broking, investment banking & other banking or finan­cial services for these companies. The information herein is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Sources for all charts & tables are CEIC & Bloomberg unless otherwise specified.

    DBS Bank Ltd., 12 Marina Blvd, Marina Bay Financial Center Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.

    PT Bank DBS Indonesia, DBS Bank Tower, 33rd floor, Ciputra World 1, Jalan Prof. Dr. Satrio Kav 3-5, Jakarta, 12940, Indonesia. Tel: 62-21-2988-4000. Company Registration No. 09.03.1.64.96422.